MRK — Merck & Company Inc · P/E 33, rev $16.61B

Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..

Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.

Use this MRK page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MRK quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MRK SEC filings page. Lician reads the product cache first so this HTML stays unique to Merck & Company Inc even when a live quote feed is slow.

Merck & Company Inc latest statements (FY2025)

Latest cached year on this hub. Full MRK income, balance, and cash tables.

  • Revenue$65.01B
  • Net Income$18.25B
  • Total Assets$136.87B
  • Total Debt$0
  • Free Cash Flow$12.36B

MRK recent filings